Laman UtamaABUS • NASDAQ
add
Arbutus Biopharma Corp
Tutup sebelumnya
$4.79
Julat hari
$4.66 - $4.82
Julat tahun
$2.71 - $5.10
Permodalan pasaran
919.31J USD
Bilangan Purata
1.25J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 529.00K | -60.49% |
Perbelanjaan pengendalian | 3.04J | -32.91% |
Pendapatan bersih | -7.74J | 60.73% |
Margin untung bersih | -1.46K | 0.61% |
Pendapatan bagi setiap syer | -0.06 | 59.57% |
EBITDA | -8.28J | 51.67% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 93.70J | -26.68% |
Jumlah aset | 97.71J | -30.43% |
Jumlah liabiliti | 20.31J | -39.46% |
Jumlah ekuiti | 77.40J | — |
Syer tertunggak | 192.32J | — |
Harga kepada buku | 11.98 | — |
Pulangan pada aset | -20.63% | — |
Pulangan pada modal | -24.39% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -7.74J | 60.73% |
Tunai daripada operasi | -5.82J | 71.95% |
Tunai daripada pelaburan | -10.02J | 16.41% |
Tunai daripada pembiayaan | 844.00K | -52.45% |
Perubahan bersih dalam tunai | -15.00J | 51.51% |
Aliran tunai bebas | -2.55J | 76.57% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
44
